ALKS vs NVST · P/E 14, rev $1.56B vs P/E 56, rev $2.51B
Alkermes Plc (ALKS) versus Envista Holdings Corp (NVST) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported NVST revenue for 2024-12-31 was $2.51B. Net income was -$1.12B. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
Not investment advice. Open the ALKS and NVST stock pages for the full models.
Not investment advice.